Additional file 1: of Therapy of nodal Follicular Lymphoma (WHO grade 1/2) in clinical stage I/II using response adapted Involved Site Radiotherapy in combination with Obinutuzumab (Gazyvaro) - GAZAI Trial (GAZyvaro and response adapted Involved-site Radiotherapy): a study protocol for a single-arm, non-randomized, open, national, multi-center phase II trial
Laila KĂśnig
Martin Dreyling
Jan DĂźrig
Marianne Engelhard
Karin Hohloch
Andreas Viardot
Mathias Witzens-Harig
Meinhard Kieser
Wolfram Klapper
Christiane Pott
Klaus Herfarth
10.6084/m9.figshare.9756071.v1
https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_of_Therapy_of_nodal_Follicular_Lymphoma_WHO_grade_1_2_in_clinical_stage_I_II_using_response_adapted_Involved_Site_Radiotherapy_in_combination_with_Obinutuzumab_Gazyvaro_-_GAZAI_Trial_GAZyvaro_and_response_adapted_Involved-/9756071
SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) 2013 Checklist: Recommended items to address in a clinical trial protocol and related documents. (DOC 236 kb)
2019-08-31 08:23:17
Follicular lymphoma
Low-dose radiotherapy
Obinutuzumab
Anti-CD20 antibody
Involved site radiotherapy
PET/CT